These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18854513)

  • 1. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
    Bos WH; Nielen MM; Dijkmans BA; van Schaardenburg D
    Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 4. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
    Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
    van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP
    Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
    Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
    Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
    [No Abstract]   [Full Text] [Related]  

  • 8. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?
    Laskari K; Ahmadi-Simab K; Lamken M; Csernok E; Gross WL; Hellmich B
    Ann Rheum Dis; 2010 Feb; 69(2):469-71. PubMed ID: 20107034
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.
    Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
    Arthritis Rheum; 2006 Aug; 55(4):681-2; author reply 682. PubMed ID: 16874773
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 12. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis.
    Tamai M; Kawakami A; Uetani M; Takao S; Tanaka F; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Kamachi M; Huang M; Origuchi T; Ida H; Aoyagi K; Eguchi K
    Ann Rheum Dis; 2006 Jan; 65(1):133-4. PubMed ID: 16344500
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers VM
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Mofidi M; Moghadam A
    Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.
    Pratt AG; Charles PJ; Chowdhury M; Wilson G; Venables PJ; Isaacs JD
    Ann Rheum Dis; 2011 Nov; 70(11):2056-8. PubMed ID: 21622767
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis.
    Spadaro A; Riccieri V
    Ann Rheum Dis; 2005 Aug; 64(8):1241-2. PubMed ID: 16014691
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.